Neeli P - Search Results

1

The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma.

Jiang N, Zheng Y, Ding J, Wang J, Zhu F, Wang M, Sobhani N, Neeli P, Wang G, Li H, Zheng J, Chai D. Jiang N, et al. Among authors: neeli p. NPJ Vaccines. 2023 Aug 4;8(1):109. doi: 10.1038/s41541-023-00706-x. NPJ Vaccines. 2023. PMID: 37542081 Free PMC article.

2

Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials.

Sobhani N, Scaggiante B, Morris R, Chai D, Catalano M, Tardiel-Cyril DR, Neeli P, Roviello G, Mondani G, Li Y. Sobhani N, et al. Among authors: neeli p. Cancer Treat Rev. 2022 Sep;109:102429. doi: 10.1016/j.ctrv.2022.102429. Epub 2022 Jun 22. Cancer Treat Rev. 2022. PMID: 35759856 Free PMC article. Review.

3

AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption.

Sobhani N, Neeli PK, D'Angelo A, Pittacolo M, Sirico M, Galli IC, Roviello G, Nesi G. Sobhani N, et al. Int J Mol Sci. 2021 May 24;22(11):5515. doi: 10.3390/ijms22115515. Int J Mol Sci. 2021. PMID: 34073713 Free PMC article. Review.

4

p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis.

Sobhani N, Roviello G, D'Angelo A, Roudi R, Neeli PK, Generali D. Sobhani N, et al. Molecules. 2021 Oct 14;26(20):6215. doi: 10.3390/molecules26206215. Molecules. 2021. PMID: 34684792 Free PMC article.

5

Expanding anti-CD38 immunotherapy for lymphoid malignancies.

Wang X, Yu X, Li W, Neeli P, Liu M, Li L, Zhang M, Fang X, Young KH, Li Y. Wang X, et al. Among authors: neeli p. J Exp Clin Cancer Res. 2022 Jun 28;41(1):210. doi: 10.1186/s13046-022-02421-2. J Exp Clin Cancer Res. 2022. PMID: 35765110 Free PMC article.

6

Erratum: Comparison of DNA vaccines with AddaS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2.

Neeli P, Chai D, Wang X, Sobhani N, Udeani G, Li Y. Neeli P, et al. iScience. 2024 Oct 15;27(10):110969. doi: 10.1016/j.isci.2024.110969. eCollection 2024 Oct 18. iScience. 2024. PMID: 39474074 Free PMC article.

7

DNA vaccines against GPRC5D synergize with PD-1 blockade to treat multiple myeloma.

Neeli P, Maza PAMA, Chai D, Zhao D, Hoi XP, Chan KS, Young KH, Li Y. Neeli P, et al. NPJ Vaccines. 2024 Oct 1;9(1):180. doi: 10.1038/s41541-024-00979-w. NPJ Vaccines. 2024. PMID: 39353958 Free PMC article.

8

Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant.

Chai D, Wang J, Fan C, Lim JM, Wang X, Neeli P, Yu X, Young KH, Li Y. Chai D, et al. Among authors: neeli p. J Hematol Oncol. 2024 Jun 18;17(1):45. doi: 10.1186/s13045-024-01566-1. J Hematol Oncol. 2024. PMID: 38886748 Free PMC article.

9

DNA-delivered monoclonal antibodies targeting the p53 R175H mutant epitope inhibit tumor development in mice.

Chai D, Wang X, Neeli P, Zhou S, Yu X, Sabapathy K, Li Y. Chai D, et al. Among authors: neeli p. Genes Dis. 2023 Jun 23;11(4):100994. doi: 10.1016/j.gendis.2023.04.027. eCollection 2024 Jul. Genes Dis. 2023. PMID: 38560504 Free PMC article.

10

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects.

Lu B, Lim JM, Yu B, Song S, Neeli P, Sobhani N, K P, Bonam SR, Kurapati R, Zheng J, Chai D. Lu B, et al. Among authors: neeli p. Front Immunol. 2024 Feb 1;15:1332939. doi: 10.3389/fimmu.2024.1332939. eCollection 2024. Front Immunol. 2024. PMID: 38361919 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters